Ropes Wealth Advisors’s Apollo Endosurgery, Inc. APEN Stock Holding History

Ropes Wealth Advisors’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-840	Closed	-$3K	–	850
2020 Q4	$3K	Hold	840	–	–	﹤0.01%	621
2020 Q3	$1K	Hold	840	–	–	﹤0.01%	600
2020 Q2	$1K	Buy	+840	New	+$1.67K	﹤0.01%	562
2020 Q1	–	Sell	-600	Closed	-$2K	–	583
2019 Q4	$2K	Sell	600 -1,000	-63%	-$2.9K	﹤0.01%	521
2019 Q3	$5K	Hold	1,600	–	–	﹤0.01%	516
2019 Q2	$5K	Hold	1,600	–	–	﹤0.01%	521
2019 Q1	$6K	Buy	1,600 +300	+23%	+$1.05K	﹤0.01%	479
2018 Q4	$4K	Hold	1,300	–	–	﹤0.01%	469
2018 Q3	$9K	Sell	1,300 -500	-28%	-$3.88K	﹤0.01%	467
2018 Q2	$13K	Hold	1,800	–	–	﹤0.01%	456
2018 Q1	$11K	Hold	1,800	–	–	﹤0.01%	453
2017 Q4	$10K	Hold	1,800	–	–	﹤0.01%	536
2017 Q3	$8K	Hold	1,800	–	–	﹤0.01%	542
2017 Q2	$14K	Buy	+1,800	New	+$14.7K	﹤0.01%	436

Other funds holding APEN

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ropes Wealth Advisors's APEN Position: Q1 2021 in Review

Ropes Wealth Advisors sold out of Apollo Endosurgery, Inc. (APEN) in Q1 2021, closing a stake of 840 shares — an estimated $3K sold.

Ropes Wealth Advisors first reported a position in APEN in Q2 2017 and held it in 14 quarters. The position peaked at $14K in Q2 2017. 42 funds tracked by Wall St. Rank hold APEN as of Q1 2021.

Ropes Wealth Advisors reported no remaining Apollo Endosurgery, Inc. position as of Q1 2021 after selling out during the quarter.
Ropes Wealth Advisors sold 840 Apollo Endosurgery, Inc. shares in Q1 2021, an estimated $3K.
Ropes Wealth Advisors first reported a position in Apollo Endosurgery, Inc. in Q2 2017 and held it in 14 quarters.
Ropes Wealth Advisors's Apollo Endosurgery, Inc. position peaked at $14K in Q2 2017.
42 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q1 2021.

Based on Ropes Wealth Advisors's 13F filing for Q1 2021, filed 12 May 2021.